{"date":"2025-06-16","count":43,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-06-16-1911-1j7xdzb","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-06-16","time":"19:11:04","subject":"公告本公司開發中新藥BRM421已向衛生福利部食品藥物管理署(TFDA)提出治療乾眼症第II期劑量探索、安全性與療效性之人體臨床試驗(IND)申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-06-16 19:11，「公告本公司開發中新藥BRM421已向衛生福利部食品藥物管理署(TFDA)提出治療乾眼症第II期劑量探索、安全性與療效性之」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-06-16-1909-1oj2zvc","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"19:09:53","subject":"代重要子公司育禾管理顧問股份有限公司公告會計主管異動","clause":"第11款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-06-16 19:09，「代重要子公司育禾管理顧問股份有限公司公告會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-06-16-1853-s0kpz3","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:53:47","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-06-16 18:53，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-06-16-1853-18j163t","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:53:29","subject":"公告本公司股東會決議解除董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-06-16 18:53，「公告本公司股東會決議解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-06-16-1853-tc88vo","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:53:11","subject":"公告本公司新任審計委員會委員","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-06-16 18:53，「公告本公司新任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-06-16-1852-1k354e4","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:52:52","subject":"公告本公司全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-06-16 18:52，「公告本公司全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-06-16-1852-hiebb2","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:52:29","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-06-16 18:52，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-06-16-1838-1yj8e5v","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:38:48","subject":"代子公司 ENIMMUNE-RMT BIOTECH PTE. LTD.公告董事會決議通過辦理現金減資案(補充114/05/14重大訊息)","clause":"第9款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-06-16 18:38，「代子公司 ENIMMUNE-RMT BIOTECH PTE. LTD.公告董事會決議通過辦理現金減資案(補充114/05」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1825-1uqmggl","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:25:36","subject":"公告本公司114年股東常會通過解除新任董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:25，「公告本公司114年股東常會通過解除新任董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1816-2zktbj","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:16:34","subject":"公告本公司董事會決議委任第二屆永續發展委員會委員","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:16，「公告本公司董事會決議委任第二屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1816-1u2ien9","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:16:16","subject":"公告本公司董事會決議委任第五屆審計委員會委員","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:16，「公告本公司董事會決議委任第五屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1815-hx12oz","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:15:54","subject":"公告本公司董事會決議委任第六屆薪酬委員會委員","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:15，「公告本公司董事會決議委任第六屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1815-9769qc","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:15:28","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:15，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1815-ua2xyz","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:15:09","subject":"公告本公司114年股東常會董事改選當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:15，「公告本公司114年股東常會董事改選當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-06-16-1814-ds864w","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"18:14:45","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-06-16 18:14，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-06-16-1748-sqgrt0","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:48:58","subject":"公告本公司法人董事代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-06-16 17:48，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-16-1731-1d2uyxw","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:31:49","subject":"公告本公司114年股東常會通過解除新任董事競業禁止限制","clause":"第21款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-16 17:31，「公告本公司114年股東常會通過解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-06-16-1731-16wvjn6","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-06-16","time":"17:31:22","subject":"公告本公司舉辦興櫃前法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-06-16 17:31，「公告本公司舉辦興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-16-1731-buvjit","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:31:13","subject":"公告本公司董事會推選董事長案","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-16 17:31，「公告本公司董事會推選董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-16-1730-hx12oz","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:30:16","subject":"公告本公司董事會決議委任第六屆薪酬委員會委員","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-16 17:30，「公告本公司董事會決議委任第六屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-06-16-1727-wo98fq","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:27:35","subject":"公告本公司買回庫藏股期間屆滿及執行狀況","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-06-16 17:27，「公告本公司買回庫藏股期間屆滿及執行狀況」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-16-1727-bbdt5u","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:27:00","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)","clause":"第6款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-16 17:27，「公告本公司114年股東常會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-06-16-1726-ds864w","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:26:15","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-06-16 17:26，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-06-16-1721-2sivja","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"17:21:24","subject":"公告本公司114年股東常會決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-06-16 17:21，「公告本公司114年股東常會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-16-1646-jk53wa","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"16:46:38","subject":"公告本公司庫藏股執行期間屆滿與實際執行情形","clause":"第35款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-16 16:46，「公告本公司庫藏股執行期間屆滿與實際執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-16-1646-1vme99a","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"16:46:05","subject":"公告本公司調整114年度第1季現金股利配息率","clause":"第14款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-16 16:46，「公告本公司調整114年度第1季現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-16-1645-1pzr3x3","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"16:45:37","subject":"公告本公司114年5月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-16 16:45，「公告本公司114年5月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-06-16-1621-1ocw5wp","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"16:21:12","subject":"公告本公司一一四年現金增資收足股款暨現金增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-06-16 16:21，「公告本公司一一四年現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-06-16-1611-1nil193","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"16:11:11","subject":"公告本公司114年第二次私募普通股訂價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-06-16 16:11，「公告本公司114年第二次私募普通股訂價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-06-16-1611-1rdrqda","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-06-16","time":"16:11:05","subject":"本公司歐洲再授權合作伙伴Averoa取得腎病新藥上市許可","clause":"第51款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-06-16 16:11，「本公司歐洲再授權合作伙伴Averoa取得腎病新藥上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-16-1554-13qqg7g","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"15:54:30","subject":"公告本公司法人董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-16 15:54，「公告本公司法人董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-16-1551-1aglqrz","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"15:51:49","subject":"公告本公司TAH3311取得台灣「ApixabanFilm Product and Uses Thereof」等2項發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-16 15:51，「公告本公司TAH3311取得台灣「ApixabanFilm Product and Uses Thereof」等2項發明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-06-16-1530-fmxyhw","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"15:30:42","subject":"本公司向TFDA提交申請新藥AD17002臨床二期試驗案用於治療中度至重度嗜酸性白血球型氣喘","clause":"第44款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-06-16 15:30，「本公司向TFDA提交申請新藥AD17002臨床二期試驗案用於治療中度至重度嗜酸性白血球型氣喘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-06-16-1527-ds864w","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"15:27:05","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-06-16 15:27，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-06-16-1516-cxyt6s","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"15:16:59","subject":"公告本公司114年股東常會通過解除本公司董事(含獨立董事)及其代表人競業禁止之限制","clause":"第22款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-06-16 15:16，「公告本公司114年股東常會通過解除本公司董事(含獨立董事)及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-06-16-1515-ds864w","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"15:15:13","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-06-16 15:15，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-06-16-1445-v1gwxu","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"14:45:46","subject":"公告本公司調整現金股利配息率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-06-16 14:45，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-06-16-1357-ds864w","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"13:57:43","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-06-16 13:57，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-06-16-1200-ev1mf7","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"12:00:14","subject":"本公司114年股東常會通過解除董事競業禁止案","clause":"第22款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-06-16 12:00，「本公司114年股東常會通過解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-06-16-1159-ds864w","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"11:59:54","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-06-16 11:59，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-16-1047-1fqkmsr","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"10:47:09","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-16 10:47，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-06-16-1024-1fqkmsr","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-16","time":"10:24:41","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-06-16 10:24，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-06-16-0841-d0rieh","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-06-16","time":"08:41:37","subject":"本公司114年現金增資催繳期間屆滿暨股票發放事宜","clause":"第53款","fact_date":"2025-06-16","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-06-16 08:41，「本公司114年現金增資催繳期間屆滿暨股票發放事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}